Counseling of female veterans about risks of medication-induced birth defects

Journal of General Internal Medicine

Volumn 28, Issue SUPPL.2, 2013, Pages

  Schwarz, Eleanor Bimla ^a   Mattocks, Kristin ^f,g   Brandt, Cynthia ^b,e   Borrero, Sonya ^a,c   Zephyrin, Laurie C ^d   Bathulapalli, Harini ^b   Haskell, Sally ^d,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Center for Health Equity Research and Promotion   (United States)

^d Veterans Administration Central Office   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^f VA Central Western Massachusetts Healthcare System   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Birth defects; Contraceptive counseling; Preconception care; Veterans; Women's health

Indexed keywords

ALPRAZOLAM; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CAPTOPRIL; CLONAZEPAM; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LISINOPRIL; LORAZEPAM; LOSARTAN; LOSARTAN POTASSIUM; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TERATOGENIC AGENT; VALSARTAN;

ADULT; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; COUNSELING; CROSS-SECTIONAL STUDY; DRUG INDUCED DISEASE; FEMALE; FETUS RISK; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEALTH CARE UTILIZATION; HUMAN; MIDDLE AGED; NORMAL HUMAN; PREMENOPAUSE; PRESCRIPTION; VETERAN; VETERANS HEALTH;

ABNORMALITIES, DRUG-INDUCED; ADULT; AFGHAN CAMPAIGN 2001-; COUNSELING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAQ WAR, 2003-2011; LONGITUDINAL STUDIES; PREGNANCY; PRENATAL CARE; PROSPECTIVE STUDIES; RISK FACTORS; VETERANS;

EID: 84886089924     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2240-0     Document Type: Article

References (28)

1. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2006 period linked birth/infant death data set. Natl Vital Stat Rep. 2010;58 (17):1-31. Epub 2010/09/08.
2. Centers for Disease Control and Prevention. Update on overall prevalence of major birth defects-Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep. 2008;57(1):1-5. Epub 2008/01/11.
3. Centers for Disease Control and Prevention. Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects-United States, 2003. MMWR Morb Mortal Wkly Rep. 2007;56 (2):25-9. Epub 2007/01/19.
4. Schwarz EB, Maselli J, Norton M, Gonzales R. Prescription of teratogenic medications in United States ambulatory practices. Am J Med. 2005;118(11):1240-9. Epub 2005/11/08.
5. National Center for Veterans Analysis and Statistics. Veteran Population. 2007 [cited 2009 November 2]; Available from: Http://www1.va.gov/vetdata/page. cfmpg=15.
6. Schwarz EB, Postlethwaite DA, Hung YY, Armstrong MA. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med. 2007;147(6):370-6. Epub 2007/09/19.
7. Schwarz EB, Longo LS, Zhao X, Stone RA, Cunningham F, Good CB. Provision of potentially teratogenic medications to female veterans of childbearing age. Med Care. 2010;48(9):834-42. Epub 2010/08/14.
8. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398-407.
9. Lee E, Maneno MK, Smith L, Weiss SR, Zuckerman IH, Wutoh AK, et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf. 2006;15(8):537-45.
10. Haskell SG, Mattocks K, Goulet JL, Krebs EE, Skanderson M, Leslie D, et al. The burden of illness in the first year home: Do male and female VA users differ in health conditions and healthcare utilization. Womens Health Issues. 2011;21(1):92-7. Epub 2010/12/28.
11. Fritsche MD, Ables AZ, Bendyk H. Opportunities missed: Improving the rate of contraceptive counseling or provision when prescribing reproductive- aged women potentially teratogenic medications in a family medicine resident clinic. Contraception. 2011;84(4):372-6. Epub 2011/09/17.
12. Morrical-Kline KA, Walton AM, Guildenbecher TM. Teratogen use in women of childbearing potential: An intervention study. J Am Board Fam Med. 2011;24(3):262-71. Epub 2011/05/10.
13. Eisenberg DL, Stika C, Desai A, Baker D, Yost KJ. Providing contraception for women taking potentially teratogenic medications: A survey of internal medicine physicians' knowledge, attitudes and barriers. J Gen Intern Med. 2010;25(4):291-7. Epub 2010/01/21.
14. Parisi SM, Zikovich S, Chuang CH, Sobota M, Nothnagle M, Schwarz EB. Primary care physicians' perceptions of rates of unintended pregnancy. Contraception 2012;86(1):48-54.
15. Freed RD, Chan PT, Boger KD, Tompson MC. Enhancing maternal depression recognition in health care settings: A review of strategies to improve detection, reduce barriers, and reach mothers in need. Fam Syst Health. 2012;30(1):1-18. Epub 2012/03/21.
16. Yawn BP, Dietrich AJ, Wollan P, Bertram S, Graham D, Huff J, et al. TRIPPD: A practice-based network effectiveness study of postpartum depression screening and management. Ann Fam Med. 2012;10(4):320-
17. Epub 2012/07/11.
18. Schwarz EB, Parisi SM, Handler SM, Koren G, Cohen ED, Shevchik GJ, et al. Clinical Decision Support to Promote Safe Prescribing to Women of Reproductive Age: A Cluster-Randomized Trial. J Gen Intern Med. 2012;27(7):831-8.
19. Raebel MA, Carroll NM, Kelleher JA, Chester EA, Berga S, Magid DJ. Randomized trial to improve prescribing safety during pregnancy. J Am Med Inform Assoc. 2007;14(4):440-50. Epub 2007/04/27.
20. Santucci AK, Gold MA, Akers AY, Borrero S, Schwarz EB. Women's perspectives on counseling about risks for medication-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2010;88(1):64-9. Epub 2009/07/29.
21. Shenolikar RA, Balkrishnan R, Hall MA. How patient-physician encounters in critical medical situations affect trust: Results of a national survey. BMC Heal Serv Res. 2004;4(1):24. Epub 2004/09/09.
22. Stepanikova I, Mollborn S, Cook KS, Thom DH, Kramer RM. Patients' race, ethnicity, language, and trust in a physician. J Health Soc Behav. 2006;47(4):390-405. Epub 2007/01/24.
23. Thom DH, Hall MA, Pawlson LG. Measuring patients' trust in physicians when assessing quality of care. Health Aff (Millwood). 2004;23 (4):124-32. Epub 2004/08/21.
24. Lee JS, Tamayo-Sarver J, Kinneer P, Hobgood C. Association between patient race/ethnicity and perceived interpersonal aspects of care in the emergency department. J Natl Med Assoc. 2008;100(1):79-85. Epub 2008/02/19.
25. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28(1):47-58. Epub 2001/10/02.
26. Thom DH, Kravitz RL, Bell RA, Krupat E, Azari R. Patient trust in the physician: Relationship to patient requests. Fam Pract. 2002;19(5):476-
27. Epub 2002/10/03.
28. Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR. Linking primary care performance to outcomes of care. J Fam Pract. 1998;47(3):213-20. Epub 1998/09/30.